NutraLife BioSciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NLBS research report →
Companywww.nutralifebiosciences.com
NutraLife BioSciences, Inc. , together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products.
- CEO
- Edgar Ward
- IPO
- 2014
- Employees
- 12
- HQ
- Coconut Creek, FL, US
Price Chart
Valuation
- Market Cap
- $17.66K
- P/E
- -0.00
- P/S
- 0.03
- P/B
- -0.02
- EV/EBITDA
- -0.83
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 13.34%
- Op Margin
- -713.77%
- Net Margin
- -929.99%
- ROE
- 2832.87%
- ROIC
- -184.06%
Growth & Income
- Revenue
- $626.62K · -50.10%
- Net Income
- $-5,827,507 · -101.65%
- EPS
- $-0.04 · -102.02%
- Op Income
- $-4,472,644
- FCF YoY
- 62.05%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -15.21
- Avg Volume
- 0
Get TickerSpark's AI analysis on NLBS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 12, 18 | Ward Edgar | sell | 25,000 |
| Oct 15, 18 | Ward Edgar | sell | 20,000 |
| Oct 15, 18 | Ward Edgar | sell | 15,000 |
| Oct 16, 18 | Ward Edgar | sell | 50,000 |
| Oct 17, 18 | Ward Edgar | sell | 19,000 |
| Oct 18, 18 | Ward Edgar | sell | 16,000 |
| Oct 24, 18 | Ward Edgar | sell | 10,735 |
| Oct 12, 18 | Ward Edgar | sell | 25,000 |
| Oct 15, 18 | Ward Edgar | sell | 20,000 |
| Oct 15, 18 | Ward Edgar | sell | 15,000 |
Our NLBS Coverage
We haven't published any research on NLBS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NLBS Report →